SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-030450
Filing Date
2021-05-27
Accepted
2021-05-27 16:23:41
Documents
68
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmea-10q_20210331.htm   iXBRL 10-Q 2175138
2 EX-4.4 bmea-ex44_356.htm EX-4.4 41265
3 EX-31.1 bmea-ex311_9.htm EX-31.1 20210
4 EX-31.2 bmea-ex312_8.htm EX-31.2 20202
5 EX-32.1 bmea-ex321_7.htm EX-32.1 9072
6 EX-32.2 bmea-ex322_6.htm EX-32.2 9070
  Complete submission text file 0001564590-21-030450.txt   6694605

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bmea-20210331.xsd EX-101.SCH 43771
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmea-20210331_cal.xml EX-101.CAL 39875
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmea-20210331_def.xml EX-101.DEF 151599
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20210331_lab.xml EX-101.LAB 345349
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20210331_pre.xml EX-101.PRE 279124
12 EXTRACTED XBRL INSTANCE DOCUMENT bmea-10q_20210331_htm.xml XML 928879
Mailing Address 726 MAIN STREET REDWOOD CITY CA 94063
Business Address 726 MAIN STREET REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40335 | Film No.: 21973040
SIC: 2834 Pharmaceutical Preparations